Skip to main content
Livermore
Livermore
ZHEN

Samalin Investment Counsel, LLC

SEC CIK
0001544366
Latest filing
Jul 27, 2026

NVO holding history

Novo Nordisk A S in every 13F filed by Samalin Investment Counsel, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NVO overviewAll 13F holders of NVOFull Q2 2026 holdings

Shares (Q2 2026)
17,321
Value
$830.4K
% of portfolio
0.3%
Quarters held
22
Since Q1 2021
Holdings of NVO by Samalin Investment Counsel, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202617,321$830.4K0.3%+7,315+73.1%AddedHolders
Q1 202610,006$367.7K0.1%−1,317−11.6%ReducedHolders
Q4 202511,323$576.1K0.2%+616+5.8%AddedHolders
Q3 202510,707$594.2K0.2%+3,728+53.4%AddedHolders
Q2 20256,979$481.7K0.2%+372+5.6%AddedHolders
Q1 20256,607$458.8K0.2%−452−6.4%ReducedHolders
Q4 20247,059$607.3K0.3%−470−6.2%ReducedHolders
Q3 20247,529$896.4K0.4%−475−5.9%ReducedHolders
Q2 20248,004$1.14M0.5%+7+0.1%AddedHolders
Q1 20247,997$1.03M0.5%+126+1.6%AddedHolders
Q4 20237,871$814.3K0.4%−241−3.0%ReducedHolders
Q3 20238,112$737.7K0.4%−84−1.0%ReducedConverted for a 2-for-1 splitHolders
Q2 20234,098$663.1K0.4%−10.0%ReducedHolders
Q1 20234,099$652.3K0.4%+18+0.4%AddedHolders
Q4 20224,081$552.3K0.3%−198−4.6%ReducedHolders
Q3 20224,279$426.0K0.3%−79−1.8%ReducedHolders
Q2 20224,358$486.0K0.3%+51+1.2%AddedHolders
Q1 20224,307$478.0K0.3%00.0%UnchangedHolders
Q4 20214,307$482.0K0.3%−15−0.3%ReducedHolders
Q3 20214,322$415.0K0.3%+156+3.7%AddedHolders
Q2 20214,166$349.0K0.2%−47−1.1%ReducedHolders
Q1 20214,213$284.0K0.2%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.